These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2094905)

  • 21. [Inhibition of gamma-amylase of the rabbit liver by biogenic amines and products of their oxidative deamination].
    Popova IA; Verevkina IV
    Vopr Med Khim; 1983; 29(6):120-3. PubMed ID: 6422628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of monoaminergic systems in morphine-induced respiratory depression.
    Meldrum MJ; Isom GE
    Neuropharmacology; 1981 Feb; 20(2):169-75. PubMed ID: 6163106
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulatory role for biogenic amines in the cerebral cortex. Microiontophoretic studies.
    Reader TA; Ferron A; Descarries L; Jasper HH
    Brain Res; 1979 Jan; 160(2):217-29. PubMed ID: 761065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential influence of dopaminergic and noradrenergic afferents on their target cells in the rat prefrontal cortex.
    Thierry AM; Godbout R; Mantz J; Pirot S; Glowinski J
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():139A-140A. PubMed ID: 1498784
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biogenic monoamines and convulsion potential of the brain].
    Vediaev FP; Sergienko NG
    Usp Fiziol Nauk; 1984; 15(1):55-75. PubMed ID: 6322467
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of morphine dependence on some specific effects mediated by monoaminergic and GABAergic systems.
    Buckett WR
    Psychopharmacology (Berl); 1979; 66(3):233-8. PubMed ID: 231277
    [No Abstract]   [Full Text] [Related]  

  • 27. Brain norepinephrine, dopamine, and 5-hydroxytryptamine concentration abnormalities and their role in the high seizure susceptibility of epileptic chickens.
    Johnson DD; Jaju AT; Ness L; Richardson JS; Crawford RD
    Can J Physiol Pharmacol; 1981 Feb; 59(2):144-9. PubMed ID: 7225941
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential regulation of fronto-executive function by the monoamines and acetylcholine.
    Robbins TW; Roberts AC
    Cereb Cortex; 2007 Sep; 17 Suppl 1():i151-60. PubMed ID: 17725997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of monoamines in the recovery of the conditioned reflex activity of rats following extirpation of the frontal cortex].
    Grekhova TV; Kudrin VS; Miroshnichenko II; Romanova GA
    Biull Eksp Biol Med; 1987 Jan; 103(1):12-4. PubMed ID: 3801640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auto-tolerance to the endogenous opioids and sleep.
    Gillman MA; Sandyk R
    Med Hypotheses; 1985 Apr; 16(4):393-5. PubMed ID: 4010578
    [No Abstract]   [Full Text] [Related]  

  • 31. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents.
    Millan MJ; Lejeune F; Gobert A
    J Psychopharmacol; 2000 Jun; 14(2):114-38. PubMed ID: 10890307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nonselective effect of selective antidepressants.
    Montgomery SA
    Adv Biochem Psychopharmacol; 1982; 32():49-55. PubMed ID: 6178265
    [No Abstract]   [Full Text] [Related]  

  • 33. Biogenic amines in the regulation of wakefulness and sleep.
    Hilakivi I
    Med Biol; 1987; 65(2-3):97-104. PubMed ID: 3309491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biogenic amines and sleep (author's transl)].
    Matsumoto J
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1719-24. PubMed ID: 7029638
    [No Abstract]   [Full Text] [Related]  

  • 35. Supraspinal monoaminergic involvement in the blockade of recurrent inhibition of the monosynaptic reflex.
    Sinclair JG; Sastry BS
    Neuropharmacology; 1974 Aug; 13(8):741-7. PubMed ID: 4280526
    [No Abstract]   [Full Text] [Related]  

  • 36. Schizophrenia: some current neurochemical approaches.
    Rodnight R
    J Neurochem; 1983 Jul; 41(1):12-21. PubMed ID: 6345723
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular and molecular aspects of transmitter release: calcium monoamine dynamics.
    Radouco-Thomas S
    Adv Cytopharmacol; 1971 May; 1():457-75. PubMed ID: 4148192
    [No Abstract]   [Full Text] [Related]  

  • 38. Cholinergic modulation through biogenic amines during development of the chick spinal cord.
    Thiriet G; Kempf E; Ebel A
    Brain Res Dev Brain Res; 1994 Mar; 78(1):102-8. PubMed ID: 8004766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Participation of cerebral monoamines in hypothalamic regulation of ACTH secretion].
    Shaliapina VG; Rakitskaia VV
    Usp Fiziol Nauk; 1976; 7(3):145-60. PubMed ID: 185834
    [No Abstract]   [Full Text] [Related]  

  • 40. Actions of amino acids, amines and neuropeptides on target cells in the mammalian central nervous system.
    Zieglgänsberger W
    Prog Brain Res; 1982; 55():297-320. PubMed ID: 6187042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.